NCT04532645 2025-09-23
OVAL-1
AstraZeneca
Completed
Clinical Trials
11 trialsNCT07151911 2025-09-03
ROYAL
Azienda Ospedaliero-Universitaria di Modena
Recruiting
NCT04152941 2023-09-06
RETROLA
ARCAGY/ GINECO GROUP
Completed
NCT04774406 2023-06-06
Arterial Hypertension Related to PARP Inhibitors (ArteRIB)
University Hospital, Caen
Completed
NCT05440578 2022-07-01
First-line Olaparib Combined With Bevacizumab Maintenance Therapy
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Unknown
NCT05081765 2021-10-18
The Effect of Glucose Level and Diabetes Mellitus on Ctrough of Olaparib
Poznan University of Medical Sciences
Unknown
NCT04774627 2021-09-23
Pancytopenia Related to PARP Inhibitors (PancytoRIB)
University Hospital, Caen
Completed
NCT05044091 2021-09-14
HOPEI
Jiangsu Cancer Institute & Hospital
Unknown
NCT04582552 2021-01-20
ROMP
Jiangsu Cancer Institute & Hospital
Unknown
NCT02506816 2020-11-30
Polen
MedSIR
Completed
NCT03925233 2019-04-24
Breast Cancer Treatment Based on Organ-like Culture
Xijing Hospital
Unknown